AT&T and More Telecom Stocks That Can Survive the SpaceX Threat
SpaceX will eventually launch a mobile telecom business, but not as soon as investors fear. There are still plenty of stocks in the sector that could pay off.
Why This Pharma Pro Likes J&J, Lilly, and Merck
Despite rising interest rates and the uncertainty of Midterm elections, Asad Haider of Goldman Sachs sees promise in Big Pharma and biotech.
Options ETFs Are Hot. Beware the Trade-Offs.
These pricey, complex strategies appeal to income-hungry and skittish investors—but some can cap your upside and leave you exposed to market downsides.
With Midterms Ahead, a Snapshot of the Trump Economy in 7 Charts
The president has repeatedly promised lower prices, higher growth, and more jobs. His administration has produced mixed results.
Long Read
The Latest Headlines
Your Retirement
Stranded Retirement Accounts Are Piling Up to the Tune of $43 Billion
Costly maintenance fees eat into workplace retirement accounts with balances of less than $7,000 when an employee leaves a company.
Barron's Columnists
America's 250
Homeownership Helped Make America. It’s Slipping Away for Millions.
This year, Barron’s has published a series of articles linking the birth and growth of America with the rise of financial markets. Today: Why buying a home is so hard these days.
Barron's Live
Health and Fitness
When It Comes to AI, the Doctor Is Always In
Our writer has health questions that he doesn’t want to waste a doctor’s time on. There are others that he only wants a human to answer.
This Stock Faces a Beautiful Future After Completing Its Makeover
Estée Lauder stock is too cheap, with turnaround efforts finally taking effect.
Long Read
A Slow Job Market Isn’t Holding This Staffing Firm Back as Its Stock Soars
Robert Half’s results point to improving staffing demand, while compliance consulting offers another source of growth.
2 minute read
Western Digital Earnings Fail to Kick-Start Stock
Western Digital handily beats expectations for its fiscal first-quarter earnings, but it wasn’t enough to get the stock back on track.
3 minute read
October 26, 2026
What a Blue Wave Would Mean for Wall Street
The midterm elections will put some industries in the crosshairs. What to expect in AI, healthcare, and beyond.
Long Read
Korea and Taiwan Built Economies on AI. One Failed IPO Shows Their Fragility.
Thetwo economies now risk entering a tech version of the “resource curse,” writes William Pesek.
Long Read
Who Will Buy an American Sellout?
Cracks in the U.S.-Europe relationship over Ukraine have consequences for investors, Christopher Smart writes.
Long Read
The Mooch on His Broken Record, the Midterms, and Some Advice for Trump
Anthony Scaramucci made headlines for being fired after only 11 days as White House press secretary.
Long Read
PG&E CEO to California Politicians: Stop Stepping on Our Stock Price
Last month, the California state legislature kicked the can down the road on wildfire liability protection for utilities. PG&E’s stock got zapped.
Long Read
What’s the Ideal Retirement Withdrawal Rate? Capital Group Has Two Suggestions.
The variable-dollar method calls for a 5% to 5.5% drawdown and could carry less risk of asset depletion than a fixed-dollar method.
2 minute read
Former LPL Advisor Pleads Guilty to Fraud in Scheme That Cost Firms $3.3 Million
Prosecutors say that Andrew Komarow made a series of unfunded electronic transfers and attempted to recoup the money through high-risk options trading.
2 minute read
UBS Financial Advisor Team With $1 Billion in Client Assets Jumps to RBC
The Nepa/Susco wealth management team expands RBC’s presence in western Pennsylvania.
2 minute read
Check out Barron's Advisor Rankings
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Find an Advisor
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Recently Viewed Tickers
SymbolPriceChange% Chg
U.S. Stock Movers
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| AI OKTO Corp. (AIOK) | 182.82% | $12.02 |
| Lycia Therapeutics Inc. (LYCA) | 66.67% | $30.00 |
| Bolt Biotherapeutics Inc. (BOLT) | 49.64% | $6.27 |
| IMC Rare Earths Ltd. (IMC) | 28.43% | $8.99 |
| Black Hawk Acquisition Corp. Cl A (BKHA) | 25.87% | $5.40 |